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Abstract
Background: In recent years, Iran has made significant developments in the field of health sciences. However, the
question is whether this considerable increase has affected public health. The research budget has always been
negligible and unsustainable in developing countries. Hence, using the Payback Framework, we conducted this
study to evaluate the impact of health research in Iran.
Methods: By using a cross-sectional method and two-stage stratified cluster sampling, the projects were randomly
selected from six medical universities. A questionnaire was designed according to the Payback Framework and
completed by the principle investigators of the randomly selected projects.
Results: The response rate was 70.4%. Ten point twenty-four percent (10.24%) of the studies had been ordered by
a knowledge user organization. The average number of articles published in journals per project was 0.96, and half
of the studies had no articles published in Scopus. The results of 12% of the studies had been used in systematic
review articles and the same proportion had been utilized in clinical or public health guidelines. The results of 5.3%
of the studies had been implemented in the Health Ministry’s policymaking. 62% of the studies were expected to
affect health directly, 38% of them had been implemented, and among the latter 60% had achieved the expected
results. Concerning the economic impacts, the most common expected impact was the reduction of ‘days of work
missed because of illness or disability’ and impact on personal and health system costs. About 36% of these studies
had been implemented, and 61% had achieved the expected impact.
Conclusion: In most aspects, the status of research impact needs improvement. A comparison of Iran’s ranking of
knowledge creation and knowledge impact in the Global Innovation Index confirms these findings. The most
important problems identified were, not conducting research based on national needs, and the lack of
implementation of research results.
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Background
Where scientific development is concerned, Iran has ex-
perienced the fastest rate of growth among countries in
the Middle Eastern region in the past 30 years [1]. In the
field of health sciences it has also seen a significant de-
velopment, such that Iran’s scientific health articles pub-
lished during the years 1990–2009 was 36.5 times the
number published during 1980–1989 [1]. The important
question that arises is whether this considerable increase
in scientific production in health sciences has affected
public health and welfare. Have we tried to implement
the results as much as we have tried to produce them?
Furthermore, the research budget has always been negli-
gible and unsustainable in developing countries. Never-
theless, in Iran, the research budget has increased from
0.55% of the Gross Domestic Product (GDP) in 2001 to
0.87% in 2009, and was meant to be raised to 2.5% in
2015, although this did not happen. It appears that the
real reason behind the failure to secure a research
budget and its lack of sustenance, however, is the
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policymakers’ lack of belief in the positive impacts of re-
search compared to other investments [2]. Measuring
the impact of research and identifying the points requir-
ing intervention are the first steps toward improving re-
search impact. Moreover, by investigating the impacts of
health research we may achieve basic data for future as-
sessments of interventions.
Few studies have been conducted to examine the im-
pact of health research. The impact and benefits of
health research can be measured in two ways, namely
through top down (ecologic studies) or bottom up (case
studies) approaches [3]. In top down studies, variables
used at the global level are collected such as an assess-
ment of the association between the cost of research and
its impact on the reduction of mortality and morbidity
resulting from specific diseases [4–6]. In bottom up
studies, a number of projects are assessed for their im-
pacts. One of the most important models recommended
for assessing the impact of health research through the
bottom up approach is the ‘Payback Framework’,
presented by the Health Economic Research Group of
Brunel University London in the United Kingdom, to in-
vestigate the impact of health research [7]. In this frame-
work, the resultant benefits of health research are
classified into five categories of ‘knowledge advance-
ment’, ‘capacity building’, ‘impact on decision-making’,
‘health impact’, and ‘social and economic impact’ [7–10].
In 2009, the Canadian Academy of Health Sciences in-
troduced detailed indicators for each of the domains de-
fined in the Payback Framework [11]. A small number
of studies have been conducted in developed countries
to assess the impact of research through this framework
and its proposed indicators [12–15], all of which ap-
prove its appropriateness. However, the impact of re-
search in developing countries has not yet been assessed
through this framework [16].
In order to judge the impact of research, three succes-
sive questions must be answered: is the research per-
formed tailored to local needs? Are the research results
implemented? And, are the desired results achieved?
The present study was designed and conducted using
the Payback Framework to address the applicability of
these three questions in Iran.
Methods
Target population and sampling
Based on university size and capacity, Iran’s universities
of medical sciences are classified into three categories.
Here, we applied a two-stage stratified cluster sampling
to stratify the universities according to the three categor-
ies and we selected two from each stratum. Prior to
2007, universities were not required to register their pro-
ject data in electronic databases, and therefore data ex-
traction prior to that date was not possible. The present
study includes the list of projects completed by 2007
and 2008 by the selected universities. The projects were
randomly selected from each university, with 200 pro-
jects being selected from type 1 universities and 100
projects from the other two categories. Since the num-
ber of completed projects in type 3 universities was very
low, these were all included in the study.
Based on recommendations made by previous studies,
in order to provide an accurate picture of the impact of
research, sampling must be purposeful and based on var-
iables affecting impact, such as the type of study and the
activities undertaken to disseminate and implement the
research results, or not [17]. However, the documenta-
tion available from the universities’ Deputies of Research
had not classified the studies based on their types, and
therefore we were unable to conduct sampling based on
these grounds. Further, due to the lack of available data,
sampling based on the activities undertaken to dissemin-
ate results or the impact research was not possible.
Moreover, performing a survey on all the research per-
formed at all six universities was not possible in terms of
human power and costs. Therefore, under the existing
circumstances, random sampling was the best choice.
Each academic member (principle investigator of each
project) completed the questionnaire for the selected
project; if someone had many completed projects, only
one of their projects was included in the study.
Design and standardization of the questionnaire
A questionnaire was developed using the indicators pre-
sented in the ‘Making an Impact’ report [11] and studies
conducted in Hong Kong [12] and Australia [13] to
measure the impact of health research based on the
Payback Framework.
The questionnaire provided to the researchers first ex-
plained the objective of the study and then asked re-
searchers to specify their type of research on the basis of
the following three classifications:
▪ The classification proposed by the Organization for
Economic Co-operation & Development (OECD) [17];
▪ The classification proposed by the Australian
National Health and Medical Research Council [18];
▪ The classification based on the methods of the study.
Then, questions were asked for each impact domain,
as indicated below.
Knowledge advancement
Researchers were asked to indicate the articles published
in journals and presented at conferences (the articles
specified in the questionnaire were searched for in
Scopus and their citation rates were retrieved).
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Capacity building
Researchers were asked whether the research project was
a thesis and the number of students involved in it;
whether the research team had acquired new skills;
whether there had been empowerment of the study’s tar-
get group (participatory research); the degree of strength-
ening of organizational research resources; the channels
through which all or some of the infrastructures required
by the project were achieved; whether research budgets
for future projects had been facilitated from the same or
other organizations; and whether the project results had
been utilised by the researcher (of the same project) and/
or other researchers to define further projects.
Impact on decision-making
The researchers were asked about the utilization of re-
search results in systematic reviews relevant to decision
making; the utilization of research results in documenta-
tions relevant to decision making, including clinical
guidelines or public health guidelines, health technology
assessment (HTA), educational content for patients and/
or the public, policy briefs, policy bills, guidelines, and/
or legislations of executive organizations; the utilization
of research results in book compilation and development
of educational content for professional groups (students’
continuing education and/or training); the utilization of
research results in policymaking in the local context,
directly or indirectly, inside and outside the Ministry of
Health and Medical Education (MOHME); the registra-
tion of domestic or international patents; and whether
the aforementioned research was conducted upon the
demand of a specific organization and/or policymakers
and managers and/or the industry.
Health impact
The researchers were asked to define the expected im-
pact of their research results on the level of health (such
as the prevalence and incidence of disease, quality of life
and/or life expectancy), on the status of health determi-
nants (such as modifiable risk factors, social determi-
nants and bio-environmental determinants), and on the
quality of health service provision (acceptability, accessi-
bility, appropriateness, effectiveness, efficacy and safety)
as well as the extent of implementation of results,
achievement of the desired result in practice, and the
share of research results in the changes created.
Economic impact
The researchers were asked about the expected impact
of research results with regards to a direct effect on the
production of materials or consumer services, optimiz-
ing the earlier goods and/or products (increasing quality
and/or reducing production costs), creating knowledge-
based entrepreneurship, decreasing days of work missed
because of illness or disability, and the impact on direct
patient costs and the health system, as well as on the ex-
tent of implementation of results, achievement of the
desired result in practice, and the share of research re-
sults in the changes created.
The questionnaire is available in Additional file 1.
Questionnaire validity
We used expert opinion to investigate the face and con-
tent validity and to identify other domains not considered
in the Payback Framework and indicators. To this end, we
invited academic experts from various disciplines to par-
ticipate in the panel. Sixteen experts from the following
specialties participated in the panel: drug management
and economy, neurology, neurosurgery, nutritional sci-
ences, endocrinology and metabolism, cardiovascular dis-
eases, psychiatry, traditional medicine, pharmacology,
sports medicine, community medicine, health services
management, and general physicians. We then asked the
participants to complete the questionnaire for one of their
projects that had been completed 3 years prior. Then, all
the sections and questions were discussed in succession.
The discussions were audio-recorded and transcribed
upon permission from the participants. The research team
examined the changes requested in the panel, and imple-
mented them in the questionnaire upon approval.
Questionnaire reliability
We used the test–retest method for this purpose. In the
first round, the questionnaire was sent to 14 individuals.
After a month, the questionnaire was sent to them again.
The reliability of the questions was measured with
Kappa. Nine questions had kappa < 0.6; by changing the
structure of the questions and their wordings, we tried
to raise their reliabilities. Furthermore, if their research
results had been implemented in decision-making and/
or resulted in health and economic impacts, we asked
researchers to provide documentation to this effect. At
this stage, we realized that bringing forth such documen-
tation was difficult for the researchers and therefore they
preferred to avoid choosing the ‘yes’ option. Thus, we
re-considered our request and asked them only to name
the documentation. Then, taking into account the re-
sponses given and the type of study (methodological
classification), the research team decided about the val-
idity of the responses.
To examine the number of article citations, the titles
that had been outlined by the researchers in the ques-
tionnaire were searched in Scopus from January to May
2015, and their citations were registered.
Analysis
Double entry of data (of the completed questionnaires)
was performed. Eventually, the two databanks were
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compared with Epi Info software, the inconsistent cases
were examined, and the final file was produced.
Considering that stratified cluster sampling was per-
formed, the stratification and cluster effects were consid-
ered in the analysis. We performed data analysis with
Stata 13 and survey (svy) commands. Standard error cal-
culation was not possible for some of the variables due
to strata with single sampling units. Under these condi-
tions, standard error was calculated by removing the ef-
fect of weighting.
Regarding the section related to the health and eco-
nomic impacts, since some of the questions were corre-
lated content-wise, whereas some were combined with
each other, so that the health and economic impacts were
presented with one and five indicators, respectively.
The study has been approved by the Institutional Re-
view Board of Tehran University of Medical Sciences
which abides by the Helsinki Declaration.
Results
Overall, of the 402 research projects, 283 project execu-
tives completed the questionnaires (70.4% response rate).
According to the researchers, 10.24% (SE = 0.02) of the
studies had been ordered by a specific organization and/or
policymaker, manager and/or the industry. The results
have been presented in separate tables for each of the
Payback Framework’s domains (Tables 1, 2, 3, 4 and 5).
Discussion
The current study was conducted to investigate the im-
pact of health sciences research in Iran through the bot-
tom up approach by the Payback Framework.
To judge the appropriateness of impact, we need an
acceptable standard for each of the questions and do-
mains, which does not currently exist, and is itself one
of the challenges of assessing research impact [19]. Ap-
praising some of the questions is not easy; nevertheless,
the least benefit of these data is that they can be used as
basic data for future assessments.
The strengths of the study include the large num-
ber of projects from various universities, and the
acceptable response rate, which strengthens the trust
in the results obtained.
Nevertheless, one of its most important limitations is
the study method involving using researchers’ opinions
[20], the major presumption of which is that their re-
sponses are valid. Although this presumption is largely ac-
ceptable, considering that the content of the questions
was new to the researchers, certain measures had to be
taken to raise the validity of the responses. Another weak-
ness of the study is the unavailability of project costs,
which is a significant variable in performing knowledge
translation activities and for research impact. Although
project costs had been included in the questionnaire, the
number of missing replies was too high and invalid, so we
were unable to analyse the given responses.
Knowledge advancement
The average number of articles produced from each pro-
ject was different from what was observed in previous
studies; 0.96 versus 2.3 in ‘primary research impact’ in
Australia [13] and 5.4 in ‘health service research impact’
in Hong Kong [12]. Although it would have been more
realistic to judge the appropriateness of this number had
we had access to project costs, considering that a third
of the studies had not produced any publications and
that more than half of publications had not been in-
cluded in Scopus, we may deduce that article production
from research projects as high as would be desired.
Moreover, the number of articles presented in confer-
ences is also small, which indicates the little interaction
among researchers. Half of the articles produced had
been included in Scopus, but had been cited fewer than
5.5 times. Thus, the quality of the knowledge produced
requires particular attention.
The distribution of studies does not match the country’s
needs; only 10% were of the experimental developmental
type. Considering the country’s need for such studies,
where the goal is to implement research-derived informa-
tion or practical experience to produce materials, novel
products or devices, innovative procedures, systems or
new services, and/or major improvement of already
Table 1 Knowledge advancement in the projects completed by 2006 and 2007
Impact Relative frequency estimate, % (standard error)
Projects that have produced no articles 33 (0.04)
Projects that have at least one article published in Scopus 50 (0.09)
Impact Mean (standard error)
The average number of citations made to the article in Scopus 11.3 (1.8)a
(The median of this index is 5.5)
The average number of articles published in journals per project 0.96 (0.14)
The average number of articles presented at conferences per project 0.13 (0.03)
aStandard error was calculated by removing the effect of weighting
Yazdizadeh et al. Health Research Policy and Systems  (2016) 14:56 Page 4 of 10
existing products [17], this figure is small. Furthermore,
almost 44% of the studies were basic science studies with
specific applied goals. As Wooding et al. [15] stated in
their study examining the impact of cardiovascular re-
search, basic science studies that have a defined clinical
application are more influential than pure basic science
studies. Only about 20% of studies were health services re-
search and/or public health research. These studies usu-
ally address local issues. Some research results are
applicable in all settings, e.g. research on the efficacy of
drugs. However, some issues, such as the burden of dis-
ease or the best way to deliver effective interventions,
need local answers. Therefore, every country needs to pro-
duce local evidence for its local health issues [16]. In light
of the limited resources available in developing countries,
the need to conduct these types of studies is greater. Only
1% of the studies were systematic reviews, while these
studies have a special place in policymaking [21–23].
Capacity building
Half the studies were theses, which culminate in educat-
ing and training researchers. Iran ranks fourth in the
Global Innovation Index 2015 report on tertiary educa-
tion [24]; hence, its growth in the higher education arena
seems to have played a significant role in its scientific
development. The average number of students per re-
search project in the current study is similar to the num-
ber reported in Britain’s ‘asthma research impact’ study
by Hanney et al. [9].
Furthermore, over two-thirds of the projects have re-
sulted in the acquisition of new skills by the research
team. About one-third of the studies conducted resulted
in empowering the target group. However, considering
that a small number of projects have been conducted
with community participation or another stakeholder,
this ratio is not surprising. Approximately a third of the
studies have led to the strengthening of the research or-
ganization’s resources. However, the accuracy of this
proportion is difficult to ascertain.
Overall, 13.9% of the research projects facilitated the
securing of research grants from other organizations,
which indicates the need for that research and the trust
the organizations have in the researchers. Therefore,
one may hope that the results of these 13.9% research
studies will be implemented. Moreover, a specific
organization, policymaker, manager, and/or the indus-
try have ordered 10.24% of the studies. Other studies
in Iran have estimated this figure at 11.8% [25] and
16% [26]. This figure is similar to that of securing re-
search grants from other organizations.
Table 3 Capacity building by the projects completed by 2006 and 2007
Impact Relative frequency percent,
% (standard error)
Thesis for one degree 47.3 (0.03)
Thesis for two degrees 1.5 (0.009)
The average number of students per project 0.6 (0.07)
Acquisition of new skills in the research group 77.3 (0.03)
Empowerment of the target group 32.5 (0.03)
Strengthening the organization’s research resources 30.6 (0.03)
Preparing part or all of the required infrastructures of the project through another channel 34 (0.05)
Facilitating the securing of research budget from other organizations 13.9 (0.01)
Utilization of project results by the researcher and/or other researchers to define the following projects 47.7 (0.06)
Table 2 Estimates of relative frequencies of projects completed by 2006 and 2007 for different classifications, respectively
The classification proposed by Europe’s OECD
Experimental developmental Applied Basic
10.8% (0.03) 80.2% (0.04) 9% (0.01)
The classification proposed by the Australian national health and medical research council
Public health Clinical research Health services research Strategic basic research Pure basic
research
9% (0.01) 29.3% (0.02) 11.5% (0.02) 44.1% (0.03) 6% (0.01)
Classification based on method of study
Descriptive
observational
Analytical
observational
Interventional Systematic
review
Diagnostic
value of tests
Laboratory
studies
Design and production of equipment,
software, medicines or chemical substances
Others
22.5% (0.03) 34.8% (0.02) 15.0% (0.02) 1% (0.01) 2.4% (0.01) 15.6% (0.02) 4.3% (0.02) 4.7% (0.02)
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Almost half the project results had been used by the re-
searcher (themselves) or other researchers to define future
projects. This rate was 32% in another study conducted in
Iran [26], whereas in studies conducted in other countries
it was reported at 23%, 44.9% and 65% [9, 12, 13]. This
shows that half of the studies are not related to their sub-
sequent studies, a point worth reflecting upon. The reason
behind this matter must be sought in the researchers’ in-
centives toward research topic selection.
Impact on decision-making
A total of 12% of the study results had been utilized
in systematic review studies. This figure is strikingly
different from the 100% rate reported by Reed et al.
[13] in Australia. The reasons behind the lack of
utilization of research results in systematic reviews
include the lack of availability of these studies and
their poor quality. Nevertheless, since half the stud-
ies have not published their articles in Scopus, this
number is not surprising.
Regarding the utilization of research results in docu-
mentations required for decision-making, the most com-
mon application was in policy bills, guidelines and/or
legislations of executive organizations. The least number
of cases of application were in HTA and policy briefs,
which, considering the small number of HTA and policy
briefs produced in the country, is not beyond expect-
ation. Nevertheless, the fact that, in spite of their rele-
vancy, only 16.35% of studies have been applied in policy
documents is a major problem. A study investigating the
impact of primary research in Australia reported the rate
of information development for policymaking at 77%
[13], which is considerably different from our results.
The above matter also holds true for book compilation
and educational content development, as these materials
can also influence decision-makers.
The rate of research result application in policy-
making (directly or indirectly) varied from 0.93% (out-
side MOHME) to 29% (local policymaking). Elsewhere,
this rate varies from 13% in Britain’s ‘asthma research
impact’ study [9] to 31% in the study on ‘primary re-
search impact’ in Australia [13]. Therefore, the figures
observed here greatly differ from those in other
countries.
Health and economic impact
A little over half of the studies could have directly influ-
enced health; however, only a third of them have been
implemented. Nevertheless, in cases where they have
been implemented, half have achieved the desired result,
which indicates that half have not influenced health. In a
country with limited resources for research, this figure
may seem high, but the worrisome issue is the minor
implementation of results, which necessitates serious in-
terventions. Overall, 14% of studies have resulted in
changes in health outcomes in the present study, which
varies from the 10% reported by the British ‘asthma re-
search impact’ study [9] and the 50% by the ‘primary re-
search impact’Australian study [13].
We observed the same pattern with regards to eco-
nomic impact. The interesting point of this section is
that the number of studies that were expected to result
in knowledge-based entrepreneurship was small. How-
ever, had the results of these studies been implemented,
Table 4 Impact on decision making by the projects completed by 2006 and 2007
Questions Percentage of relevant
projects,
% (standard error)
Percentage of relevant projects
that have been utilized,
%a (standard error)
Utilization in systematic reviews NA 12 (0.04)
Utilization in clinical guideline or public health guideline 71 (0.03) 11.7 (0.03)
Utilization in health technology assessment 34.0 (0.03) 1.6 (0.008)
Utilization in educational content for patient and/or the public 34.4 (0.02) 9.8 (0.02)
Utilization in policy briefs 27.5 (0.02) 2.0 (0.01)
Utilization in policy bills, guidelines and/or legislations of executive organizations 47.2 (0.04) 16.3 (0.03)
Utilization in book compilation 96.6 (0.009) 8.2 (0.03)
Utilization in development of educational content for professional groups
(education or continuing education of academic students)
93.2 (0.02) 3.4 (0.02)
Utilization in policymaking by the Health Ministry (directly or indirectly) 85.2 (0.02) 5.3 (0.01)
Utilization in policymaking outside the Health Ministry (directly or indirectly) 81 (0.02) 0.9 (0.006)
Utilization in decision making in local contexts 87.7 (0.02) 29.0 (0.006)
Registration of domestic patents 77.1 (0.02) 1.5 (0.008)
Registration of inventions or foreign patents 76 (0.02) 0.5 (0.003)
aAll the percentages in the column are dependent on the previous column
NA: The researchers believe that any type of project can be relevant in terms of being utilized in systematic reviews
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they would have culminated in the desired result. Over-
all, 9.94% of researchers stated that their research results
had the capability of producing a new product or im-
proving an existing one. Yet, upon comparing this figure
with the number of registered patents, we observed that
although 10% of the studies could have registered pat-
ents, fewer than 2% had resulted in patent registration.
This too, indicates the lack of implementation of re-
search results in their potential pathway. Here, we ob-
served that 1.44% of studies had resulted in the
manufacturing of a new product or optimization of an
already existing one, which, if compared to the 17% re-
ported in the British ‘asthma research impact’ study [9],
is a very small figure.
The share of research in the changes brought about was
not evenly distributed, although, overall, most projects
were believed to have created approximately 25% of the
changes. However, the share of influential projects that
had affected the direct costs of patients and the health sys-
tem, and those that had culminated in the manufacture of
a product or optimizing one was greater than 25%.
This result was not unexpected either; generally, we
do not expect different types of studies to have the same
impact. Nevertheless, care must be taken in interpreting
these data, as, in addition to the type of study, know-
ledge exchange activities and contextual factors are other
important influential factors affecting research, which
we have not investigated in this study.
Table 5 Health and economic impact of the projects completed by 2006 and 2007
Relative frequency
of projects with the
expected impact, %
(standard error)
Relative frequency of
projects whose results
have been applied, %
(standard error)a
Relative frequency of
projects which have
achieved the expected
impact, % (standard error)a
Health impact The share of
research in the
final change, %
Relative frequency of
the share of research
in the final change, %b
Direct impact on health,
health determinants, or
quality of delivered services
62 (0.04) 38 (0.05) 59.7 (0.04) <25 45.9 (0.09)
25–50 23.32 (0.08)
50–75 5.42 (0.05)
>75 25.36 (0.07)
Economic impact
Production of new products
or improvement of already
existing products
9.5 (0.03) 27.7 (0.08)b 55 (0.20)b <25 5 (0.29)
25–50 0
50–75 25 (0.25)
>75 25 (0.25)
Knowledge-based
entrepreneurship
8.5 (0.02) 9.4 (0.07)b 100 (0.00)b <25 100 (0.00)
25–50 –
50–75 –
>75 –
Reduction of days of work
missed because of illness or
disability
36.9 (0.06) 36.6 (0.05) 60.8 (0.09)b <25 47.71 (0.14)
25–50 22.55 (0.11)
50–75 10.16 (0.07)
>75 19.57 (0.11)
Reduction of patient direct costs 42.5 (0.02) 37.8 (0.04) 63.9 (0.08)b <25 22.37 (0.09)
25–5 30.37 (0.10)
50–75 24.88 (0.09)
>75 22.37 (0.09)
Reduction of health systems costs 45.3 (0.04) 32.6 (0.03) 59.8 (0.08)b <25 22.44 (0.11)
25–50 12 (0.07)
50–75 45.14 (0.12)
>75 20.41 (0.09)
aAll the percentages in the column are dependent on the previous column
bStandard error was calculated by removing the effect of weighting
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The comparison of our results with those of other
studies is not easy, as the various studies have been
conducted with different sample sizes and questions.
Moreover, the impact of research is dependent on the
context and infrastructure of each country. Hence,
the results of different studies from different settings
are not directly comparable. We have stated the de-
scriptive characteristics of similar studies in Table 6.
In general, there is no standard for the ideal level of
research impact. Nevertheless, upon comparing our
results with those of other studies extracted, we ob-
served that, in all its aspects, the research impact was
smaller in the present study.
Based on our results, the most important problems
identified are not conducting research based on national
needs and the lack of implementation of research results.
The lack of a systematic process for determining and
disseminating health research priorities was introduced
Table 6 Summarized results of studies that have examined the impact of health research
Variables examined Publicly funded health and
health services research Hong
Kong, Kwan et al., 2007 [12]
Primary health care research,
Australia, Reed et al., 2011 [13]
Asthma research UK,
Hanney et al., 2013 [9]
Cardiovascular research, UK,
Canada, Australia, Wooding et
al., 2014 [15]
The organization
examined
Health and health research fund All primary health care research
studies funded by the National
Health Medical Research Council,
the Aboriginal Health Medical
Research Council, the General
Practice Evaluation Program, the
Cooperative Research Council for
Aboriginal Health, and the Primary
Health Care Research, Evaluation
and Development
Charity funding English department of health
Canadian Institutes of Health
Research
Charities: The Heart Foundation
(Australia), Heart and Stroke
Foundation of Canada, British
Heart Foundation, UK Stroke
Association
Type of studies Public health and health services
research
Interventional descriptive Not specified Basic clinical
Number of projects 205 41 153 29
Response rate 86.8% 49% 59% 100%
Results: knowledge
advancement
5.4 articles per project 295 projects
have been cited in ISI and social
sciences, wherein each article has
been cited 1.9 times on average
2.3 articles per project 4 articles per project All the studies had academic
impact (basic science studies had
greater impact than clinical ones);
however, the wider impact of
clinical studies was greater than
that of basic science studies
Results: capacity
building
44.9% used for future research 94% used for staff development 45 PhD graduates, 21
MDs
65% used for future research 23% used for future
research
Results: impact on
decision-making
35.4% impact on informing policy
(treatment guideline and protocol,
reference standard, Cochrane
review)
100% have been utilized in
guidelines and systematic reviews
13% of projects have
influenced policies
77% provided information for
policymaking
49.4% created change in
behaviour or clinical practice in
managers, service providers and
the public
31% influenced policymaking
85% provided information for
organizations and 73% influenced
it/them
Results: health and
economic impacts
42.1% caused health services
benefit (adoption of cost effective
strategies, qualitative
improvement, improved
effectiveness of public health
policies, selling of intellectual
property rights)
70% improved service delivery 10% have influenced
health
58% used in clinical practice 17% of projects have
resulted in
manufacture of
products
50% improved health outcome For every pound
invested, 1.40 pounds
were secured for the
next projects from
sources other than
Asthma UK
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as a barrier in another study in Iran [27]. As mentioned
by Meagher et al. “it is impractical to attempt to meas-
ure something which one has not deliberately tried to
bring about” [28]. Therefore, if we want to improve the
impact of research on decision making (academic or
non-academic), we should promote the implementation
of research results first. The barriers to implementation
of research findings in health decision-making in devel-
oping countries have been investigated in a couple of
studies [27, 29–31]. Some of these barriers are related to
the knowledge generating organizations, and the others
are related to knowledge user organizations. Others are
seen in the interactions between the two groups. To elim-
inate these barriers, interventions must be aimed at both
sectors and at different levels. Where achievement of re-
sults upon applying them is concerned, half the studies
have attained the desired results, but the other half have
not. This section requires further study to identify the fac-
tors affecting this field. The gap between knowledge gen-
eration and utilization is a grave problem, which is not
only present in the health sector, but also exists in other
sectors. In the Global Innovation Index 2015, Iran ranked
24th in the knowledge creation sector, whereas it ranked
114th among 141 countries in the knowledge impact sec-
tor [24]. These figures clearly point to the know-do gap.
Two types of research impact must be differentiated
from each other in research impact assessment. Firstly,
the result of each study is used to design a new one and,
secondly, if a research finding has direct application in
health and economy it should be implemented. The target
audiences of the first group are researchers, and those of
the second are policymakers and managers, service pro-
viders, patients, the community, and the industry. Each of
these study groups requires special interventions to in-
crease research uptake.
Another noteworthy point is that we have examined the
studies that have been completed by 2007 and 2008. In
the years that followed, certain changes were introduced
that may have changed the status of Payback indices. Fol-
lowing the revolution and war, the country’s research pol-
icies were focused on increasing scientific productions, a
goal that was achieved [1]. Thereafter, macro-level policies
were aimed at conducting purposeful research, such as
priority-setting in the health system and development of
‘Iran’s Health Innovation and Science Development Plan
by 2025’. The latter is a subset of the ‘Comprehensive Sci-
entific Map of the Country’ [32], published in 2009. In this
regard, certain interventions were undertaken in Iran’s
universities of medical sciences to strengthen the applica-
tion of research results, as follows:
▪ Establishment of knowledge translation units
▪ Establishment of the ‘Office of Industrial Relations’ in
some universities
▪ Conducting knowledge translation workshops
▪ Allocation of budget to knowledge translation
activities
▪ Considering promotion scores for academic members
for making their research results applicable
▪ Considering the application of research results during
evaluation of universities of medical sciences and
research centres by MOHME
▪ Allocation of 2% of the university budget to applied
research
▪ Holding workshops on evidence-informed policymaking
in various sectors of MOHME
▪ Promoting the production of systematic reviews and
clinical guidelines
▪ Establishment of incubators (places wherein research
results that can be commercialized are presented to
companies that have been formed by graduates and
initial entrepreneurship support is provided) [33, 34]
Conclusion
In most aspects, research impact needs improvement. A
comparison of Iran’s ranking of knowledge creation and
knowledge impact in the Global Innovation Index con-
firms these findings. The most important problems identi-
fied were not conducting research based on national
needs and the lack of implementation of research results.
In the future, in addition to overcoming the barriers that
have existed toward research impact assessment, new
indices should be considered for evaluating impact and
the pathways for achieving it. Among the indices, co-
authorship (at individual and organizational level) indi-
cates the impact of research on establishing research net-
works among researchers, and can also predict the impact
of research. Moreover, the identification and measurement
of indices that can quantitatively indicate the path of re-
search should be investigated in future studies.
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